Europe Breast Cancer Screening Market Expected to Witness the Highest Growth By 2027 major key companies profiled like Koninklijke Philips N.V.,Hologic, Inc.,Becton, Dickinson and Company,Myriad Genetics, Inc.,Siemens Healthcare AG

Increasing incidence of breast cancerand presence of prominent players in the breast cancer screening market, as well as robust research and development activities, are among the prominent factors propelling the market growth. However, thehigh cost associated with breast cancer screening restrains the growth of the market.

Get Sample Copy of this Report @

Key Players:

1. Koninklijke Philips N.V.
2. Hologic, Inc.
3. Becton, Dickinson and Company
4. Myriad Genetics, Inc.
5. Siemens Healthcare AG
6. Exact Sciences Corporation
7. OncoCyte Corporation
8. POC Medical Systems
9. DanaherCorporation
10. General Electric Company

The Europe breast cancer screening market was valued at US$ 1,231.82 million in 2019 and is projected to reach US$ 1,586.46 million by 2027; it is expected to grow at CAGR of 4.3%from 2020 to 2027.

Growing number of breast cancer is mainly due to unhealthy habits, such as smoking, unhealthy diet or infections. As per the Globocan 2019 report, the total number of breast cancer cases in Germany were 71,888 in 2018, and about19,376 breast cancer deaths were reported. Breast cancer is the most common cancer type in Germany. Additionally, according to Cancer Research UK Statistics there were 55,176 new cases of breast cancer and 11,399 cancer deaths from2015 to 2017. Many collaborations are made to spread awareness; for instance, Cancer Research UK and Avon Foundation together launched Avon?s Breast Cancer Promise, a multi-year pledge to educate women about breast cancer.

This collaboration promises to reach 100 million women each year with vital information about breast cancer. Moreover, the statistics mentioned that nearly150 new breast cancer cases are diagnosed every day in females. Breast cancer in males is not so common in the UK?as per the cancer research UK there were about 390 new cases in 2017. Furthermore, in Spain, the growing prevalence of breast cancer is likely to demand for screening technologies. Globocan report stated that in 2018, in Spain, 32,825 new cases of breast cancer were found and 6,421 breast cancer deaths were reported.

Avail Discount on this Report:

The Europe breast cancer screening market is segmented into test type and end user. Based on test type, the market isfurther segmentedinto imaging test, Immunohistochemistrytest, genetic test, and blood marker test. The imaging test segment held the largest share of the market in 2019 and is anticipated to register the highest CAGRduring the forecast period. Based on end user, the market is further segmentedinto hospitals, diagnostic centers, cancer institute?s, and research laboratories. The hospitals segmentheld the largest share of the market in 2019; moreover, it is expected to register fastest growth during 2020?2027.

Fundamentals of Table of Content:

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.5 Market by Application
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Europe Breast Cancer Screening Market Size
2.2 Europe Breast Cancer Screening Growth Trends by Regions
2.3 Industry Trends

3 Market Share by Key Players
3.1 Europe Breast Cancer Screening Market Size by Manufacturers
3.2 Europe Breast Cancer Screening Key Players Head office and Area Served
3.3 Key Players Europe Breast Cancer Screening Product/Solution/Service
3.4 Date of Enter into Europe Breast Cancer Screening Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Europe Breast Cancer Screening Sales by Product
4.2 Global Europe Breast Cancer Screening Revenue by Product
4.3 Europe Breast Cancer Screening Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Europe Breast Cancer Screening Breakdown Data by End User

About Premium market insights: is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Sameer Joshi                                
Call: US: +1-646-491-9876, Apac: +912067274191
Email: [email protected]

Posted by on Tuesday July 07 2020, 5:59 PM EDT. All trademarks acknowledged. Filed under Healthcare, Life Sciences, Medical Devices. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in